Controlling risk factors like diet and exercise can help reduce heart disease, a major issue for many people, including those with MS.
The study found that heart diseases are a leading cause of death and disability worldwide. Since 1990, the number of people suffering from heart problems has more than doubled, reaching over 626 million in 2023. Many of these heart issues can be linked to controllable factors like poor diet, high blood pressure, and lack of exercise. Interestingly, while smoking rates have gone down, other risks like being overweight and not being active have gone up. This means that changing our habits can significantly impact our heart health.
MS patients and caregivers should pay attention to these findings because heart health is critical for overall wellness. Just as we need to maintain a clean and safe home, we also have to take care of our bodies by managing what we eat and how much we move. For MS patients, keeping the heart healthy can help improve energy levels and reduce fatigue. Caregivers can encourage healthy habits and support MS patients in making better lifestyle choices. Ultimately, everyone can play a part in their health by being aware of these risk factors.
The study focuses on heart disease trends and may not include all aspects of MS or its specific impacts. While it shows the importance of managing risk factors, it does not provide specific treatment advice for MS. It's also important to remember that individual health situations can vary widely, so consulting with healthcare providers is crucial.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of the American College of Cardiology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.